Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Dose-finding Study Using Pentostatin for Injection in the Treatment of Steroid-refractory aGvHD

This study has been terminated.
Sponsor:
Information provided by:
Astex Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00032773
First received: April 2, 2002
Last updated: October 12, 2009
Last verified: June 2005
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: No date given
  Primary Completion Date: No date given